PsiThera: Valuation, Funding & Investors
PsiThera is a biotechnology company harnessing biologically relevant protein states and computational intelligence to create oral drugs for immune and inflammatory diseases — therapeutic areas long reliant on injectables. Integrating biophysics, computational modeling, and mechanistic biology enables PsiThera’s expert drug hunters to discover new therapeutic opportunities and optimized drugs.
Leadership & Board
- Current Number of Employees
- 34
- Current LinkedIn Followers
- 5,699
Latest Estimated Valuation
- Total Amount Raised
- $48M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $48M
- Latest Funding Round
- Series A
Employee Trend
PsiThera had 34 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
PsiThera had 5,699 followers as of November 16, 2026. The number of followers increased by 57 (1.01%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 10, 2025 | Series A | $47.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Samsara BioCapital | Series A |
| Lightstone Ventures | Series A |
| YK Bioventures | Series A |
| Roivant | Series A |
| Eurofarma Ventures | Series A |
Similar Companies
A snapshot of private companies similar to PsiThera, helping you discover and navigate related company profiles.
Related News and Analysis







